What is the difference between molecular medicine and conventional medicine?

Thanks to the technologically advanced and efficient methods available to us today, we are able to develop more effective treatment concepts that act on the fundamental causes of disease. Molecular medicine aims to influence disease-causing patterns of reaction at the cellular level. Every cell receives signals, to which it reacts in different ways. Certain reaction patterns result in disease. We have dedicated ourselves to identifying and understanding the underlying disease-causing mechanisms that lead to osteoarthritis. In order to do this it is necessary to decode cellular functions. Working with this understanding of biological fundamentals, we have developed several new treatment approaches, including Regenokine® and exosome therapy®, that act on the cells at the molecular level. As well as orthopaedic disorders, these methods have shown promise in treating immune disorders such as psoriasis and neurodermatitis by reversing not only symptoms but the cellular responses that lead to disease.

Molecular orthopaedics studies the biological causes of diseases of the musculoskeletal system and develops biological treatments that address these causes at the molecular level. One of the main triggers of joint disease has been found to be the protein interleukin-1 (IL-1). This pro-inflammatory cytokine is one of the main culprits behind arthritis. This protein, which is an important part of the body`s immune system, has the ability to alter the function of other cells. This can be positive when it allows the body`s "repair troops" to move in quickly to fight infection or other kinds of damage, but it can also trigger inflammatory processes that lead to degeneration and breakdown of cartilage. It is these negative effects that are primarily responsible for the pain and stiffness of osteoarthritis.

Dedicated research has revealed another protein that counteracts the effects of interleukin‑1. This is the natural adversary of interleukin‑1, known as interleukin-1 receptor antagonist (IL-1RA). This "good protein" protects cartilage by keeping the pro-inflammatory proteins in check. A number of studies have also discovered which blood cells produce these "good proteins" with their protective and disease-inhibiting effects.

By means of a special procedure that includes the addition of proteins, we stimulate the patient`s own blood to increase production of the "good proteins" and send them to the site of inflammation. In this way we help your body to heal itself - without the chemicals or other substances foreign to the body that form the basis of other treatment methods.